New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareThymagen vs Syn-Ake

Thymagen vs Syn-Ake

Side-by-side comparison of key properties, dosing, and research.

Immune Support
Thymagen
Skin & CosmeticAnti-Aging & Longevity
Syn-Ake
Summary
Thymagen is a dipeptide bioregulator (Glu-Asp) developed by Professor Vladimir Khavinson, tissue-specific for the thymus gland. It supports T-lymphocyte maturation, thymic function, and immune system normalization. As the thymus involutes with age (thymic atrophy), immune competence declines. Thymagen is used to support immune restoration, particularly in aging, post-illness recovery, and immunodeficiency states.
Syn-Ake is a synthetic tripeptide that mimics waglerin-1, a peptide found in the venom of the Temple viper (Tropidolaemus wagleri). It acts as a reversible antagonist of muscular nicotinic acetylcholine receptors, temporarily reducing facial muscle contraction and smoothing dynamic wrinkles. Often called a 'synthetic Botox' in cosmetic marketing.
Half-Life
Short (minutes); sustained gene-regulatory effects
Not applicable (topical; effect duration hours)
Admin Route
SubQ, Oral
Topical
Research
Typical Dose
10 mg per day
0.01–0.1% (4–8 mg/g in clinical studies)
Frequency
Daily for 10–30 days
Twice daily
Key Benefits
  • Supports thymic epithelial cell function and T-cell maturation
  • May partially restore thymic output reduced by age-related atrophy
  • Normalizes T-lymphocyte subpopulation balance
  • Supports immune recovery after illness, surgery, or chemotherapy
  • Anti-aging effects on thymic tissue
  • Complementary to Thymosin Alpha-1 and Thymalin in immune protocols
  • May improve vaccine responsiveness in older individuals
  • Reduces depth of dynamic wrinkles and expression lines
  • Reversible muscle-relaxing effect on facial muscles
  • Smooths forehead lines, crow's feet, and frown lines
  • Non-invasive alternative to injectable neurotoxins
  • Rapid onset relative to collagen-stimulating peptides
  • Well-studied in in vitro and clinical cosmetic trials
Side Effects
  • Generally well tolerated
  • Mild injection site reactions
  • No significant immunological adverse events reported
  • Generally very well-tolerated topically
  • Rare skin sensitivity or contact dermatitis
  • Theoretical neuromuscular effects at systemic doses (not relevant topically)
Stacks With